Role of sodium in dialysis

Minerva Urologica e Nefrologica

Volumn 56, Issue 3, 2004, Pages 205-213

  Charra, B ^a,b   Chazot, C ^a   Jean, G ^a   Hurot, J M ^a   Terrat, J C ^a   Vanel, T ^a   Lorriaux, C ^a   Vovan, C ^a  

^a Center of Artificial Kidney   (France)

^b Centre de Rein Artificiel de Tassin   (France)

Author keywords

Blood pressure; Diet; Extracellular space; Renal dialysis; Sodium, blood

Indexed keywords

SODIUM;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CELL VOLUME; DIALYSATE; DIALYSIS; HEMODIALYSIS PATIENT; HEMOFILTRATION; HUMAN; HYPERTENSION; INTRACELLULAR SPACE; KIDNEY FAILURE; MORBIDITY; MORTALITY; PERITONEAL DIALYSIS; REVIEW; SODIUM BALANCE; SODIUM INTAKE; SURVIVAL; ULTRAFILTRATION;

BLOOD PRESSURE; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; SODIUM; WATER-ELECTROLYTE IMBALANCE;

EID: 4544298502     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? I-Analysis of observational data among populations. BMJ 1991;302:811-4.
2. nd ed. New York: Raven Press; 1995.p.1327-33.
3. Benetos A, Yang YX, Cuche JL, Hannaert P, Safar ME. Arterial effect of salt restriction in hypertensive patients. A 9-week, randomized, double-blind, cross-over study. J Hypertens 1992;10:355-60.
4. Oliver WJ, Cohen EL, Neel JV. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo indians, a "no-salt" culture. Circulation 1975;52:146.
5. Stefanski A, Schmidt KG, Waldherr R, Ritz E. Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis. Kidney Int 1996;50:1321-6.
6. Brenner BM. Retarding the progression of renal disease. Kidney Int 2003;64:370-8.
7. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60.
8. Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Arch Intern Med 2001;135:73-87.
9. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13-8.
10. Thomson GE, Waterhouse K, Mc Donald HPJ, Friedman EA. Hemodialysis for chronic renal failure. Arch Intern Med 1967;120:153-67.
11. Acosta JH. Hypertension in chronic renal disease. Kidney Int 1982;22:702-12.
12. Blumberg A, Hegstrom RM, Nelp WB. Extracellular volume and exchangeable sodium in chronic hypertensive renal disease. In: Kerr DNS, editor. Proceedings of Europ Dial Transplant Assoc. Newcastle-upon-Tyne: Scheltema and Holima; 1964.p.199-203.
13. Norman RAJ, Coleman TG, Wiley TLJ, Guyton AC. Separate roles of sodium ion concentration and fluid volumes in salt-loading hypertension in sheep. Am J Physiol 1975;229:1068-72.
14. Guyton AC, Coleman TG, Young DB, Lohmeier TE, DeClue JW. Salt balance and long-term blood pressure control. Annu Rev Med 1980;31:15-27.
15. Kim KE, Onesti G, Swartz C. Hemodynamics of hypertension in chronic end-stage renal disease. Circulation 1972;46:456-61.
16. Koomans HA, Geers AB, Boer P, Roos JC, Dorhout Mees EJ. A study on distribution of body fluids after rapid saline expansion in normal subjects and in patients with renal insufficiency: preferential intravascular deposition in renal failure. Clin Sci 1983;64:153-60.
17. Ritzr E, Koomans HA. New insights into mechanisms of blood pressure regulation in patients with uremia. Nephrol Dial Transplant 1996;11 Suppl 2:52-9.
18. Weidmann P, Beretta-Piccoli C, Steffin F, Blumberg A, Reuii FC. Hypertension in terminal renal failure. Kidney Int 1976;9:294.
19. Campese VM, Romoff MS, Levitan D, Lane K, Massry SG. Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 1981;20:246-53.
20. Converse RL, Jacobsen TN, Toto RD, Jost CMT, Cosentino F, Fouad-Tarazi F et al. Sympathetic over-activity in patients with chronic renal failure. N Engl J Med 1992;327:1912-8.
21. Imai Y, Abe K, Otsuka Y, Sato M, Haruyama T, Ito T et al. Blood pressure regulation in chronic hypotensive and hypertensive patients with chronic renal failure. Jpn Circ J 1981;45:303-14.
22. Charra B, Calemard E, Cuche M, Laurent G. Control of hypertension and prolonged survival on maintenance hemodialysis. Nephron 1983;33:96-9.
23. Lins RL, Elseviers M, Rogiers P, Van Hoeyweghen RJ, De Raedt H, Zachee P et al. Importance of volume factors in dialysis related hypertension. Clin Nephrol 1997;48:29-33.
24. Lorell BH, Carabello BA. Left ventricular hypertrophy-Pathogenesis, detection and prognosis. Circulation 2000;102:470-9.
25. Ates K, Nergizoglu G, Keven K, Sen A, Kutlay S, Erturk S et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001;60:767-76.
26. Scribner BH. A personalized history of chronic hemodialysis. Am J Kidney Dis 1990;6:511-9.
27. Comty C, Rottka H, Shaldon S. Blood pressure control in patients with end-stage renal failure treated by intermittent dialysis. Proc Eur Dial Transplant Assoc 1964;1:209-14.
28. Onesti G, Swartz C, Ramirez O, Brest AN. Bilateral nephrectomy for control of hypertension in uremia. Trans Am Soc Artif Intern Organs 1968;14:361-6.
29. Vertes V, Cangiano JL, Berman LB, Gould A. Hypertension in end-stage renal disease. N Engl J Med 1969;280:978-81.
30. Schupack E, Merrill JP. Experience with long-term intermittent hemodialysis. Ann Intern Med 1965;62:509.
31. Comty CM, Shapiro FL. Cardiac complications of regular dialysis therapy. In: Drukker W, Parsons FM, Maher JF, editors. Replacement of renal function by dialysis. Boston, The Hague, Dordrecht, Lancaster: Martinus Nijhoff; 1983.p.595-610.
32. Cirit M, Akçiçek F, Terzioglu E, Soydas C, Ok E, Özbasli C et al. Paradoxical rise in blood pressure during ultrafiltration in dialysis patients. Nephrol Dial Transplant 1995;10:1417-20.
33. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T et al. Survival as an index of adequacy of dialysis. Kidney Int 1992;41:1286-91.
34. Ackrill P, Goldsmith DJA, Covic AA, Venning MC, Ralston AJ. Outcome of long hours self-care haemodialysis in a single unit from 1969 through 1994. Nephrology 1997;3 Suppl 1:S536.
35. Mac Gregor DO, Buttimore AL, Lynn KL, Nicholls GM, Jardine RS. A comparative study of blood pressure control with short in-center versus long home hemodialysis. Blood Purif 2001;19:293-300.
36. Zazgornik J, Biesenbach G, Forstenlehner M, Stummvoll K. Profile of antihypertensive drugs in hypertensive patients on renal replacement therapy. Clin Nephrol 1997;48:337-40.
37. Rahman M, Dixit A, Donley V, Gupta S, Hanslik T, Lacson E et al. Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis 1999;33:498-506.
38. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 2003;115:291-7.
39. Fishbane S, Natke E, Maesaka JK. Role of volume overload in dialysis-refractory hypertension. Am J Kidney Dis 1996;28:257-61.
40. Zucchelli P, Zuccala A, Santoro A, Sturani A, Degli Esposti E, Ligabue A et al. Management of hypertension in dialysis. Int J Artif Organs 1980;3:78-84.
41. Koomans HA, Roos JC, Boer P, Greyskes GG, Dorhout Mees EJ. Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Hypertension 1982;4:190-7.
42. Özkahya M, Töz H, Ünsal A, Özerkan F, Asci G, Gürgün C et al. Treatment of hypertension in dialysis patients by ultrafiltration: role of cardiac dilatation and time factor. Am J Kidney Dis 1999;34:218-21.
43. Günal AI, Duman S, Ozkahya M, Toz H, Asci G, Akçiçek F et al. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 2001;37:588-93.
44. Charra B. Control of blood pressure in long slow hemodialysis. Blood Purif 1994;12:252-8.
45. Charra B, Chazot C, Laurent G, Calemard E, Terrat JC, Vanel T et al. Clinical assessment of dry weight. Nephrol Dial Transplantat 1996;11 Suppl 2:16-9.
46. Charra B. How important is volume excess in the etiology of hypertension in dialysis patients? Semin Dial 1999;12:297-9.
47. Charra B, Bergström J, Scribner BH. Blood pressure control in dialysis patients. The importance of the lag phenomenon. Am J Kidney Dis 1998;32:720-4.
48. Wizemann V, Schilling M. Dilemma of assessing volume state: the use and the limitations of a clinical score. Nephrol Dial Transplant 1995;10:2114-7.
49. Scribner BH. Discussion. Trans Am Soc Artif Int Organs 1962;VIII:298.
50. Batistella P, de Cornelissen F, de Gaudemaris R, Contard S, Janin G. [Ambulatory blood pressure profile during 48 hours in patients treated with chronic hemodialysis Arch Mal Coeur Vaiss 1990;83:1223-7.
51. Huisman RM, de Bruin C, Klont D, Smit AJ. Relationship between blood pressure during hemodialysis and ambulatory blood pressure in between dialyses. Nephrol Dial Transplant 1995;10:1890-4.
52. Chazot C, Charra B, Laurent G, Didier C, Vo Van C, Terrat JC et al. Interdialysis blood pressure control by long hemodialysis sessions. Nephrol Dial Transplant 1995;10:831-7.
53. Savage T, Fabbian F, Giles M, Tomson CRV, Raine AEG. Interdialytic weight gain and 48-h blood pressure in haemodialysis patients. Nephrol Dial Transplant 1997;12:2308-11.
54. Sherman RA, Daniel A, Cody RP. The effect of interdialytic weight gain on predialysis blood pressure. Artif Organs 1993;17:770-4.
55. Dionisio P, Valenti M, Bergia R, Caramello E, Stramignoni E, Berto IM et al. Influence of hydration state on blood pressure values in a group of patients on regular maintenance hemodialysis. Blood Purification 1997;15:25-33.
56. Ventura JE, Sposito M. Volume sensitivity of blood pressure in end-stage renal disease. Nephrol Dial Transplant 1997;12:485-91.
57. Sulkova S, Valek A. Role of antihypertensive drugs in the therapy of patients on regular dialysis treatment. Kidney Int 1988;34 Suppl 25:S198-200.
58. Ifudu O, Dawood M, Homel P, Friedman EA. Excess interdialytic weight gain provokes antihypertensive drug therapy in patients on maintenance hemodialysis. Dial Transplant 1997;26:541-59.
59. Locatelli F, Ponti R, Pedrini LA, Costanzo R, Di Filippo S, Marai P et al. Sodium kinetics across dialysis membranes. Nephron 1984;38:174-7.
60. Flanigan MJ. Role of sodium in hemodialysis. Kidney Int 2000;58 Suppl 76:S72-8.
61. Moret K, Hassell D, Kooman JP, van der Sande F, Gerlag PG, van den Wall Bake AW et al. Ionic mass balance and blood volume preservation during a high, standard, and individualized dialysate sodium concentration. Nephrol Dial Transplant 2002;17:1463-9.
62. De Vecchi AF. Adequacy of fluid/sodium balance and blood pressure control. Perit Dial Int 1994;14 Suppl 3:S110-6.
63. de Planque BA, Mulder E, Dorhout Mees EJ. The behavior of blood and extracellular volume in hypertensive patients with renal insufficiency. Acta Med Scand 1969;186:75-81.
64. Luik AJ, Charra B, Katzarski KS, Habets J, Cheriex EC, Menheere PP et al. Blood pressure control and hemodynamic changes in patients on long time dialysis treatment. Blood Purif 1998;16:197-209.
65. Cohen EP, Salatnik L, Leach N, Ahuja M. Reduction of interdialytic weight gain: effect of low salt diet. J Am Soc Nephrol 1999;10:237A.
66. Rigby-Mathews A, Scribner BH, Ahmad S. Control of interdialytic weight gain does not require fluid restriction in hemodialysis (HD) patients. J Am Soc Nephrol 1999;10:267A.
67. Maduell F, Navarro V. Assessment of salt intake in hemodialysis. Nefrologia 2001;21:71-7.
68. Shaldon S. Dietary salt restriction and drug-free treatment of hypertension in ESRD patients: a largely abandonned therapy. Nephrol Dial Transplant 2002;17:1163-5.
69. Robson M, Oren A, Ravid M. Dialysate sodium concentration, hypertension, and pulmonary edema in hemodialysis patients. Dial Transplant 1978;7:678-9.
70. Maduell F, Navarro V, Dietary salt intake and blood pressure control in haemodialysis patients. Nephrol Dial Transplant 2000;15:2063.
71. Krautzig S, Janssen U, Koch KM, Granoleras C, Shaldon S. Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 1998;13:552-3.
72. Ang KS, Benarbia S, Boulahrouz R, Stanescu C, Charasse C, Le Cacheux P et al. [Arterial hypertension in the hemodialysis patient. A model of salt-sensitive hypertension in man]. Arch Mal Coeur Vaiss 1999;92:1023-6.
73. Donohoe P, Farmer C, Dallyn P, Kingswood JC, Goldsmith DJA, Sharpstone P. Low-sodium hemodialysis without fluid removal improves blood pressure control in chronic dialysis patients. Kidney Int 1997;52:1119.
74. Flanigan MJ, Khairullah QT, Lim VS. Dialysate sodium delivery can alter chronic blood pressure management. Am J Kidney Dis 1997;29:383-91.
75. Kooman JP, Hendriks EJM, van den Sande FM, Leunissen KML. Dialysate sodium concentration and blood pressure control in haemodialysis patients. Nephrol Dial Transplant 2000;15:554-5.
76. Tzamaloukas AH, Saddler MC, Murata GH, Malhotra D, Sena P, Simon D et al. Symptomatic fluid retention in patients on Continuous peritoneal dialysis. J Am Soc Nephrol 1995;6:198-206.
77. Mailloux LU. The overlooked role of salt restriction in dialysis patients. Semin Dial 2000;13:150-1.
78. Shaldon S. Can antihypertensive medications control BP in haemodialysis patient. Nephrol Dial Transplant 2000;15:736.
79. Hörl MP, Hörl WH. Hypertension and dialysis. Kidney Blood Press Res 2003;26:76-81.
80. Charra B, Chazot C. The neglect of sodium restriction in dialysis patients: a short review. Hemodial Int 2003;7:342-7.
81. Stewart WK, Fleming LW, Manuel MA. Benefits obtained from the use of high sodium dialysate during maintenance hemodialysis. Proc Eur Dial Transplant Assoc 1972;9:1111.
82. Sellars L, Robson V, Wilkinson R. Sodium retention and hypertension with short dialysis. BMJ 1979;1:520-1.
83. Locatelli F, Pedrini LA, Ponti R, Costanzo R, Di Filippo S, Marai P et al. Long-term haemodialysis treatment with sodium removal by convection. In: Robinson BHB, Hawkins JB, Davison AM, editors. Proceedings of European Dialysis and Transplantation Association. Paris: Pitman; 1981.p.146-52.
84. Daugirdas JT, Al-Kudsi RR, Ing TS, Norusis MJ. A double-blind evaluation of sodium gradient hemodialysis. Am J Nephrol 1985;5:163-8.
85. Henrich WL. Hemodynamic instability during hemodialysis. Kidney Int 1986;30:605-12.
86. Acchiardo SR, Hayden AJ. Is sodium modeling necessary in high flux dialysis? Am Soc Artif Intern Organs Trans 1991;37:M135-7.
87. Levin A, Goldstein MB. The benefits and side effects of ramped hypertonic sodium dialysis. J Am Soc Nephrol 1996;7:2704-6.
88. Sang LSG, Kovithavongs C, Ulan R, Kjellstrand CM. Sodium ramping in hemodialysis: a study of beneficial and adverse effects. Am J Kidney Dis 1997;29:669-77.
89. Mann H, Stiller S. Sodium modeling. Kidney Int 2000;58 Suppl 76:S79-88.
90. Petitclerc T. Festschrift for Professor Claude Jacob. Recent developments in conductivity monitoring of haemodialysis session. Nephrol Dial Transplant 1999;14:2607-13.
91. Santoro A, Mancini E, Paolini F, Cavicchioli G, Bosetto A, Zuccheli P. Blood volume regulation during hemodialysis. Am J Kidney Dis 1998;32:739-48.
92. Goldsmith DJA, Covic AA, Venning MC, Ackrill P. Ambulatory blood pressure monitoring in renal dialysis and transplant patients. Am J Kidney Dis 1997;29:593-600.
93. Mac Gregor DO, Buttimore AL, Nicholls MG, Lynn KL. Ambulatory blood pressure monitoring in patients receiving long, slow home haemodialysis. Nephrol Dial Transplant 1999;14:2676-9.
94. Charra B, Calemard E, Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996;16:35-44.
95. Katzarski KS, Charra B, Luik A, Nisell J, Divinho Filho JC, Leypoldt JK et al. Fluid state and blood pressure control in patients treated with long and short hemodialysis. Nephrol Dial Transplant 1999;14:369-75.
96. Zucchelli P, Santoro A, Zuccala A. Genesis and control of hypertension in hemodialysis patients. Semin Nephrol 1988;8:163.
97. Mailloux LU, Haley WE. Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions. Am J Kidney Dis 1998;32:705-19.
98. Hörl MP, Hörl WH. Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis 2002;59:227-44.
99. Lameire N, van Biesen W. Importance of blood pressure and volume control in peritoneal dialysis patients. Perit Dial Int 2001;21:206-11.